RT @AAPSonline: "Hydroxychloroquine use in outpatients reduces the incidence of the composite outcome of COVID-19 infection, hospitalizatio…
RT @AAPSonline: "Hydroxychloroquine use in outpatients reduces the incidence of the composite outcome of COVID-19 infection, hospitalizatio…
RT @AAPSonline: "Hydroxychloroquine use in outpatients reduces the incidence of the composite outcome of COVID-19 infection, hospitalizatio…
RT @AAPSonline: "Hydroxychloroquine use in outpatients reduces the incidence of the composite outcome of COVID-19 infection, hospitalizatio…
RT @AAPSonline: "Hydroxychloroquine use in outpatients reduces the incidence of the composite outcome of COVID-19 infection, hospitalizatio…
RT @AAPSonline: "Hydroxychloroquine use in outpatients reduces the incidence of the composite outcome of COVID-19 infection, hospitalizatio…
"Hydroxychloroquine use in outpatients reduces the incidence of the composite outcome of COVID-19 infection, hospitalization, and death. Serious adverse events were not reported and cardiac arrhythmia was rare." https://t.co/3DcVTE7oaQ
RT @Covid19Crusher: Another meta-analysis of the hydroxychloroquine randomized controlled trials reaches the conclusion of statistically si…
Otro meta-analisis de los estudios aleatorizados de la Hidroxicloroquina arrojó como resultado que la misma posee una eficacia terapéutica significativa.
Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis: Objective--To determine if hydroxychloroquine (HCQ) reduces the incidence of new illness,… https://t.co/
Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis https://t.co/iMyM6Hoipx #medRxiv